Primary Job Title Co-founder Primary Organization Mirum Pharmaceuticals
Location San Diego, California, United States Regions Greater San Diego Area, West Coast, Western US Gender Male Also Known As Alex
LinkedIn View on LinkedIn
Alejandro Dorenbaum is the Chief Medical Officer of Reneo Pharmaceuticals. Previously, he was a Chief Medical Officer at Allakos, where he achieved proof-of-concept in clinical trials for novel therapeutic antibodies targeting inflammatory cells. He also served as a Chief Medical Officer at Lumena Pharmaceutical until its acquisition by Shire.
Prior to that, Alex worked at Genentech, where he was responsible for the respiratory programs for asthma and cystic fibrosis, and at BioMarin Pharmaceutical, where he conducted the clinical development of Kuvan. He began his career at Chiron Corporation, gaining broad expertise in several areas of drug development including biologics, small molecules, and vaccines.
